Helminth Egg Derivatives As Proregenerative Immunotherapies

The authors developed a regenerative immunotherapy from the helminth Schistosoma mansoni soluble egg antigen to stimulate production of interleukin-4 and other type 2-associated cytokines, without negative infection-related sequelae.